Cargando…

Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial

The addition of fiber is one of the most important dietary means to relieve constipation through lifestyle modification. Polydextrose (PDX) has been reported in several studies to increase fecal bulk, soften stools, and increase the number of defecations. However, there are few studies on the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibarra, Alvin, Pelipyagina, Tetyana, Rueffer, Matthew, Evans, Malkanthi, Ouwehand, Arthur C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412485/
https://www.ncbi.nlm.nih.gov/pubmed/30791557
http://dx.doi.org/10.3390/nu11020439
_version_ 1783402616090263552
author Ibarra, Alvin
Pelipyagina, Tetyana
Rueffer, Matthew
Evans, Malkanthi
Ouwehand, Arthur C.
author_facet Ibarra, Alvin
Pelipyagina, Tetyana
Rueffer, Matthew
Evans, Malkanthi
Ouwehand, Arthur C.
author_sort Ibarra, Alvin
collection PubMed
description The addition of fiber is one of the most important dietary means to relieve constipation through lifestyle modification. Polydextrose (PDX) has been reported in several studies to increase fecal bulk, soften stools, and increase the number of defecations. However, there are few studies on the effect of PDX on colonic transit time (CTT). Therefore, the aim of this study was to demonstrate the effect of PDX on CTT and other aspects of gastrointestinal function during two weeks (Day 1 to Day 14), preceded by a 2-week run-in period (Day -14 to Day -1). A total of 192 adults who were diagnosed with functional constipation per Rome III criteria were recruited for the study. Participants were randomized equally into 4 groups (12 g, 8 g, or 4 g of PDX or placebo per day). The primary endpoint was CTT, assessed using radio-opaque markers and abdominal X-rays on Day 0, the baseline; and Day 15, the end of the intervention. Secondary outcomes that were measured using inventories were the patient assessment of constipation symptoms and quality of life, bowel function index, relief of constipation, bowel movement frequency (BMF), stool consistency, degree of straining, and proportion of bowel movements. Ancillary parameters and harms were also evaluated. The recruited population was not sufficiently constipated (e.g., baseline values for CTT and BMF of 42 h and 8.7 BMF/week, respectively). Despite this limitation, our results demonstrated an increased number of bowel movements when supplemented with PDX at a dosage of 12 g per day for 2 weeks. This dosage also consistently improved the secondary outcomes that were measured using inventories at Day 15, compared with the baseline. No serious or significant adverse events were reported during the study.
format Online
Article
Text
id pubmed-6412485
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64124852019-03-29 Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial Ibarra, Alvin Pelipyagina, Tetyana Rueffer, Matthew Evans, Malkanthi Ouwehand, Arthur C. Nutrients Article The addition of fiber is one of the most important dietary means to relieve constipation through lifestyle modification. Polydextrose (PDX) has been reported in several studies to increase fecal bulk, soften stools, and increase the number of defecations. However, there are few studies on the effect of PDX on colonic transit time (CTT). Therefore, the aim of this study was to demonstrate the effect of PDX on CTT and other aspects of gastrointestinal function during two weeks (Day 1 to Day 14), preceded by a 2-week run-in period (Day -14 to Day -1). A total of 192 adults who were diagnosed with functional constipation per Rome III criteria were recruited for the study. Participants were randomized equally into 4 groups (12 g, 8 g, or 4 g of PDX or placebo per day). The primary endpoint was CTT, assessed using radio-opaque markers and abdominal X-rays on Day 0, the baseline; and Day 15, the end of the intervention. Secondary outcomes that were measured using inventories were the patient assessment of constipation symptoms and quality of life, bowel function index, relief of constipation, bowel movement frequency (BMF), stool consistency, degree of straining, and proportion of bowel movements. Ancillary parameters and harms were also evaluated. The recruited population was not sufficiently constipated (e.g., baseline values for CTT and BMF of 42 h and 8.7 BMF/week, respectively). Despite this limitation, our results demonstrated an increased number of bowel movements when supplemented with PDX at a dosage of 12 g per day for 2 weeks. This dosage also consistently improved the secondary outcomes that were measured using inventories at Day 15, compared with the baseline. No serious or significant adverse events were reported during the study. MDPI 2019-02-20 /pmc/articles/PMC6412485/ /pubmed/30791557 http://dx.doi.org/10.3390/nu11020439 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ibarra, Alvin
Pelipyagina, Tetyana
Rueffer, Matthew
Evans, Malkanthi
Ouwehand, Arthur C.
Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial
title Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial
title_full Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial
title_fullStr Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial
title_full_unstemmed Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial
title_short Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial
title_sort efficacy of polydextrose supplementation on colonic transit time, bowel movements, and gastrointestinal symptoms in adults: a double-blind, randomized, placebo-controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412485/
https://www.ncbi.nlm.nih.gov/pubmed/30791557
http://dx.doi.org/10.3390/nu11020439
work_keys_str_mv AT ibarraalvin efficacyofpolydextrosesupplementationoncolonictransittimebowelmovementsandgastrointestinalsymptomsinadultsadoubleblindrandomizedplacebocontrolledtrial
AT pelipyaginatetyana efficacyofpolydextrosesupplementationoncolonictransittimebowelmovementsandgastrointestinalsymptomsinadultsadoubleblindrandomizedplacebocontrolledtrial
AT rueffermatthew efficacyofpolydextrosesupplementationoncolonictransittimebowelmovementsandgastrointestinalsymptomsinadultsadoubleblindrandomizedplacebocontrolledtrial
AT evansmalkanthi efficacyofpolydextrosesupplementationoncolonictransittimebowelmovementsandgastrointestinalsymptomsinadultsadoubleblindrandomizedplacebocontrolledtrial
AT ouwehandarthurc efficacyofpolydextrosesupplementationoncolonictransittimebowelmovementsandgastrointestinalsymptomsinadultsadoubleblindrandomizedplacebocontrolledtrial